{"entity":{"type":"insider","cik":"0001296995","url":"/insider/0001296995","json_url":"/insider/0001296995.json","name":"Sommadossi Jean-Pierre","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2004-07-29","last":"2024-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Sommadossi Jean-Pierre","source":"filing","n_filings":5,"first_seen":"2004-07-29","last_seen":"2024-09-19"}],"transactions":[{"id":2277457,"accession":"0000950170-24-108233","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-108233","line_url":"/filing/0000950170-24-108233#line-3","is_derivative":false,"issuer_cik":"0001296995","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001296995","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1841.0,"shares_display":"1,841","price_per_share":4.0019,"price_display":"4.00","price_state":"stated","total_value":7367.4979,"total_display":"7,367.50","total_whole":"7,367","shares_owned_after":5866025.0,"shares_owned_after_display":"5,866,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-19","filed_date":"2024-09-19","scope":"insider"},{"id":2277450,"accession":"0000950170-24-108233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-108233","line_url":"/filing/0000950170-24-108233#line-2","is_derivative":false,"issuer_cik":"0001296995","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001296995","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22187.0,"shares_display":"22,187","price_per_share":4.0325,"price_display":"4.03","price_state":"stated","total_value":89469.0775,"total_display":"89,469.08","total_whole":"89,469","shares_owned_after":5867866.0,"shares_owned_after_display":"5,867,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":2277445,"accession":"0000950170-24-108233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-108233","line_url":"/filing/0000950170-24-108233#line-1","is_derivative":false,"issuer_cik":"0001296995","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001296995","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33941.0,"shares_display":"33,941","price_per_share":4.0458,"price_display":"4.05","price_state":"stated","total_value":137318.4978,"total_display":"137,318.50","total_whole":"137,318","shares_owned_after":5890053.0,"shares_owned_after_display":"5,890,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-19","scope":"insider"},{"id":2237049,"accession":"0000950170-24-070965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-070965","line_url":"/filing/0000950170-24-070965#line-1","is_derivative":false,"issuer_cik":"0001296995","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001296995","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1006.0,"shares_display":"1,006","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":4024.0,"total_display":"4,024.00","total_whole":"4,024","shares_owned_after":5923994.0,"shares_owned_after_display":"5,923,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":2115301,"accession":"0000950170-24-010972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-010972","line_url":"/filing/0000950170-24-010972#line-2","is_derivative":false,"issuer_cik":"0001296995","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001296995","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56910.0,"shares_display":"56,910","price_per_share":3.845,"price_display":"3.84","price_state":"stated","total_value":218818.95,"total_display":"218,818.95","total_whole":"218,819","shares_owned_after":116557.0,"shares_owned_after_display":"116,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":4029510,"accession":"0001209191-06-029333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-029333","line_url":"/filing/0001209191-06-029333#line-1","is_derivative":false,"issuer_cik":"0001093649","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001093649","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.13,"price_display":"9.13","price_state":"stated","total_value":91300.0,"total_display":"91,300.00","total_whole":"91,300","shares_owned_after":2058269.0,"shares_owned_after_display":"2,058,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-09","filed_date":"2006-05-11","scope":"insider"},{"id":439429,"accession":"0001209191-04-038072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-038072","line_url":"/filing/0001209191-04-038072#line-1","is_derivative":false,"issuer_cik":"0001093649","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001093649","owner_cik":"0001296995","owner_name":"Sommadossi Jean-Pierre","owner_display_name":"Sommadossi Jean-Pierre","owner_url":"/insider/0001296995","role":"Director, Officer (President, CEO, Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6364.0,"shares_display":"6,364","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":89096.0,"total_display":"89,096.00","total_whole":"89,096","shares_owned_after":1963864.0,"shares_owned_after_display":"1,963,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-07-27","filed_date":"2004-07-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001593899","name":"Atea Pharmaceuticals, Inc.","url":"/issuer/0001593899","role":"Director, Officer (President, CEO, and Chairman)","n_filings":3,"first_seen":"2024-02-02","last_seen":"2024-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Director, Officer (President, CEO, Chairman)","n_filings":2,"first_seen":"2004-07-29","last_seen":"2006-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001296995","retrieved_at":"2026-08-22T20:11:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}